查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1806536

營養基因組學市場（按產品、技術、應用和最終用戶分類）—2025-2030 年全球預測

Nutrigenomics Market by Offering, Technique, Technology, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

營養基因組學市場規模預計在 2024 年達到 5.7503 億美元，預計在 2025 年將成長至 6.7141 億美元，複合年成長率為 17.26%，到 ​​2030 年將達到 14.9519 億美元。

主要市場統計數據
基準年2024年 5.7503億美元
預計2025年 6.7141億美元
預測年份 2030 14.9519億美元
複合年成長率（%） 17.26%

開發基因組學和個人化營養的交叉領域，提供個人需求的健康解決方案

營養基因組學誕生於遺傳學與營養學的交叉領域，有望徹底改變醫療保健領域。透過分析個體的基因變異，該領域能夠提供前所未有的精準飲食建議和預防干涉措施。在這個「一刀切」的醫療方案往往難以奏效的時代，營養基因組學滿足了人們對個人化醫療保健的需求，能夠將每個人獨特的基因特徵納入考慮。

革命性的技術進步和消費者需求正在推動營養基因組學研究和個人化健康策略的發展

在基因組序列測定和數據分析革命性進展的推動下，營養基因組學領域正經歷一段變革時期。高通量新一代定序平台顯著降低了基因分析所需的時間和成本，並使我們能夠更深入地了解複雜的基因-營養交互作用。因此，研究人員和從業人員現在可以探索代謝調節和飲食影響等先前難以觸及的領域。

因應貿易政策和關稅變化的複雜性，以緩解2025年營養基因體學的供應鏈中斷

2025年，美國貿易政策變化與關稅調整將波及全球營養基因體學試劑、套件及相關服務的供應鏈。對進口檢測組件徵收高額關稅，造成了成本壓力，波及範圍從原料採購到最終用戶定價。因此，製造商正在重新評估籌資策略，並評估其他區域供應商，以降低進口關稅上漲的風險。

解讀多方面的細分框架可以實現跨產品、技術、應用和最終用戶的精確定位。

市場區隔框架揭示了針對性創新和策略投資的微妙路徑。按服務分類，試劑和試劑套件（檢測開發的支柱）與一系列強大的服務（包括遺傳諮詢和研發）之間呈現出明顯的二分法。在這些服務中，遺傳諮詢已成為將複雜的基因組數據轉化為可操作的生活方式指導的重要環節，而研發服務則繼續推動檢測最佳化和新型生物標記的發現。

了解影響美洲、歐洲、中東和非洲地區以及亞太地區營養基因體學應用的區域差異和市場動態

區域動態對營養基因體學的應用有著顯著的影響，美洲、歐洲、中東和非洲地區以及亞太地區分別展現出不同的成長軌跡和市場條件。在美洲，完善的醫療保健基礎設施和較高的消費者認知度正在推動先進基因檢測服務的早期應用。尤其是美國，它擁有成熟的臨床實驗室、直銷平台和數位健康整合商生態系統，加速了基因組學洞察向個人化營養方案的轉化。

分析推動營養基因組學創新和商業化的領先產業參與者之間的策略性舉措和合作

營養基因組學領域的關鍵參與企業正在採取多管齊下的策略，以打造差異化產品組合併推動創新。領先的跨國診斷供應商正在透過整合全面的生物資訊解決方案，並推出基於次世代定序儀的、專為營養和代謝分析量身定做的試劑盒，來鞏固其市場地位。這些努力通常得到與專注於人工智慧和雲端基礎分析的科技公司的策略聯盟的支持，從而實現無縫的數據解讀和可擴展的服務部署。

實施戰術性藍圖和策略重點，以增強競爭力並推動營養基因組學領域的永續成長

為了保持競爭優勢，產業領導者應優先投資於高階分析能力和人工智慧主導的解讀引擎。這樣做將使公司能夠提高基因-營養關聯模型的準確性，並提供根據即時用戶數據不斷改進的預測性飲食建議。此外，多元化的供應鏈夥伴關係和本地化製造設施有助於減輕貿易政策波動的影響，同時確保關鍵試劑和檢測組件的持續供應。

採用整合定性見解和定量檢驗的強大調查方法，確保全面的營養基因組學情報

本報告背後的調查方法採用多階段方法，將定性洞察與定量檢驗相結合，以確保研究結果嚴謹且可操作。首先，我們與頂尖科學家、臨床醫生和產業主管進行專家訪談，以獲得關於技術趨勢、監管發展和市場動態的第一手觀點。這些原始數據有助於建立主題框架並提出假設。

整合技術發展、政策影響和細分洞察的關鍵發現，規劃營養基因組學的未來發展軌跡

在本摘要中，我們總結了關於影響營養基因組學的技術、監管和市場力量的關鍵見解。定序和數據分析領域的根本性進步正在開啟基因-營養素相互作用的新維度，而不斷變化的貿易政策則促使人們制定適應性策略，以維持供應鏈的韌性。細分框架重點在於突顯了產品、分析技術、技術、應用和最終用戶管道方面的目標機會，強調了精準定位的重要性。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章市場動態

  • 透過引入基於人工智慧的基因型和表現型預測來最佳化個人化營養攝入
  • 在不斷變化的法規結構下，直接面對消費者的營養基因組學檢測將持續擴展
  • 整合多體學資料集以識別用於飲食干預的新型生物標記
  • 食品製造商與生物技術公司合作開發基因標靶補充劑
  • 提供即時營養基因組諮詢和膳食計劃的遠距遠端醫療平台的出現
  • 利用區塊鏈技術增強消費者基因資料的隱私和安全
  • 基於 CRISPR 的營養基因組學快速代謝風險篩檢檢測進展
  • 基於人群特異性遺傳多態性研究的機能性食品開發
  • 利用微型RNA分析預測個體飲食反應和代謝結果
  • 在全球營養基因組學資料庫中使用大規模人工智慧分析的合作研究舉措

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

8. 營養基因體學市場（依產品提供）

  • 試劑和套件
  • 服務
    • 遺傳諮詢服務
    • 研發服務

9. 營養基因體學市場（依技術）

  • 血
  • 口腔拭子
  • 唾液

第10章 營養基因體學市場（依技術）

  • 生物資訊學和數據分析
  • 基因分型
  • 微陣列技術
  • 次世代定序（NGS）
  • 聚合酵素鏈鎖反應（PCR）

第 11 章營養基因體學市場（按應用）

  • 癌症預防與控制
  • 疾病管理
    • 心血管系統
      • 膽固醇
      • 高血壓
    • 糖尿病
      • 類型 1
      • 類型 2
    • 肥胖
  • 個人化營養
  • 運動營養
    • 耐力
    • 運動後
    • 鍛鍊前
  • 體重管理

第 12 章 營養基因體學市場（依最終用戶分類）

  • 診斷實驗室
  • 健身健康中心
  • 醫院和診所
  • 研究和學術機構

13.美國營養基因組市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

14. 歐洲、中東和非洲營養基因體學市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

15. 亞太地區營養基因體學市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第16章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Atlas Laboratories Ltd.
    • DNAlife
    • EliteVita
    • Genomics Research and Solutions Pvt Ltd.
    • Genosalut Balear SL
    • Genova Diagnostics Inc.
    • GX Sciences, LLC
    • HOLISTIC HEALTH INTERNATIONAL, LLC
    • LifecodeGx Ltd
    • Mapmygenome
    • myDNA Life Australia Pty Ltd.
    • NuGenomics
    • Nutrigenomix Inc.
    • Randox Health LTD
    • The Gene Box
    • Wellness Psychiatry, PLLC
    • Xcode Life

第17章 研究人工智慧

第18章 研究統計

第19章 研究聯絡人

第20章 研究報導

第21章 附錄

Product Code: MRR-036C5CF3B557

The Nutrigenomics Market was valued at USD 575.03 million in 2024 and is projected to grow to USD 671.41 million in 2025, with a CAGR of 17.26%, reaching USD 1,495.19 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 575.03 million
Estimated Year [2025] USD 671.41 million
Forecast Year [2030] USD 1,495.19 million
CAGR (%) 17.26%

Pioneering the Intersection of Genomics and Personalized Nutrition to Unlock Tailored Health Solutions That Resonate with Individual Needs

Emerging at the nexus of genetics and nutrition, the field of nutrigenomics has risen to prominence as a transformative force in health management. By analyzing individual genetic variations, this discipline offers unprecedented precision in dietary recommendations and preventive interventions. In an era where one-size-fits-all approaches often fall short, nutrigenomics responds to the demand for personalized healthcare solutions that account for unique genetic profiles.

Furthermore, recent breakthroughs in sequencing technologies and bioinformatics have accelerated the translation of genomic data into actionable nutrition strategies. As a result, practitioners can now tailor interventions that optimize metabolic pathways, mitigate disease risks, and enhance overall wellbeing. This synergy between advanced analytics and nutritional science underscores the potential of nutrigenomics to reshape preventive care paradigms.

Moreover, evolving consumer awareness around genetic predispositions and lifestyle factors has fueled an unprecedented interest in personalized nutrition. Consequently, collaboration among research institutions, healthcare providers, and commercial entities has intensified, creating an ecosystem rich in innovation. This introduction explores the foundational concepts and drivers propelling nutrigenomics to the forefront of dietary science, setting the stage for deeper analysis in subsequent sections.

Additionally, integration with digital health platforms and wearable devices is facilitating real-time monitoring of dietary adherence and metabolic responses. By seamlessly linking genetic insights to mobile applications, individuals can receive dynamic feedback and refine their nutritional plans over time. This convergence of genetics, data analytics, and user-friendly technology marks a new chapter in preventive medicine.

Looking ahead, the scalability of nutrigenomics solutions hinges on widespread access to affordable testing and robust data governance frameworks. Ethical considerations around privacy, data security, and informed consent remain paramount as stakeholders navigate this evolving landscape. Through a balanced approach that emphasizes scientific rigor and responsible stewardship, nutrigenomics is poised to deliver personalized nutrition at scale, ultimately fostering healthier populations worldwide.

Revolutionary Technological Advancements and Consumer Demands Driving the Evolution of Nutrigenomics Research and Personalized Wellbeing Strategies

The landscape of nutrigenomics is undergoing seismic shifts driven by revolutionary advancements in genomic sequencing and data analytics. High-throughput next-generation sequencing platforms have dramatically reduced the time and cost barriers associated with genetic profiling, enabling deeper insights into complex gene-nutrient interactions. Consequently, researchers and practitioners can explore previously inaccessible dimensions of metabolic regulation and dietary impact.

Moreover, the integration of artificial intelligence and machine learning algorithms has elevated the interpretative power of nutrigenomic datasets. By harnessing predictive modeling and pattern recognition, analytics platforms are now able to forecast individual responses to specific nutrients with remarkable accuracy. This evolution in computational capabilities is catalyzing the development of bespoke nutritional regimens that adapt in real time to physiological feedback.

Simultaneously, shifting consumer expectations for personalized wellness solutions have spurred the emergence of direct-to-consumer testing services and digital health ecosystems. Individuals increasingly demand transparency and immediacy in their nutritional insights, prompting service providers to innovate user-centric platforms and intuitive reporting formats. As a result, the boundary between laboratory research and consumer application has blurred, fostering a dynamic market environment.

Furthermore, regulatory bodies are evolving their frameworks to accommodate the unique considerations of nutrigenomic interventions, balancing the need for scientific validation with the imperative to protect consumer privacy. Collaborative efforts among industry consortia, academic institutions, and policy makers are forging new standards and best practices, ensuring that transformative discoveries translate into safe, reliable, and accessible solutions for all stakeholders.

Navigating the Complexities of Revised Trade Policies and Tariff Changes to Mitigate Supply Chain Disruptions in Nutrigenomics by 2025

In 2025, revised trade policies and tariff adjustments in the United States have reverberated across the global supply chain for nutrigenomics reagents, kits, and related services. The imposition of higher duties on imported assay components has introduced cost pressures that reverberate from raw material sourcing through to end-user pricing. Consequently, manufacturers are recalibrating their procurement strategies and evaluating alternative regional suppliers to mitigate exposure to elevated import levies.

Moreover, the heightened financial burden has compelled service providers to explore local manufacturing partnerships and strategic alliances that can deliver more resilient production pipelines. As a result, collaborative ventures between domestic reagent developers and contract research organizations have gained momentum. These initiatives not only address tariff-induced cost escalations but also lay the groundwork for enhanced quality control and reduced lead times.

Additionally, the tariff environment has influenced cross-border research collaborations, with some international academic partnerships reassessing project budgets to accommodate increased logistical expenses. Nevertheless, the pursuit of scientific innovation remains undeterred as stakeholders seek creative mechanisms such as bonded warehouses and tariff exemption programs to preserve momentum in method development and clinical validation studies.

Consequently, organizations that proactively adapt to these evolving trade dynamics by diversifying supply chains and investing in localized capabilities are better positioned to sustain growth. By embracing flexible manufacturing models and leveraging supportive policy instruments, companies can navigate the tariff landscape while continuing to drive advances in nutrigenomic science and personalized health.

Deciphering the Multifaceted Segmentation Framework to Enable Precision Targeting Across Offering, Technique, Technology, Application, and End User

The market's segmentation framework reveals nuanced avenues for targeted innovation and strategic investment. When categorized by offering, a distinct dichotomy emerges between reagents & kits, which serve as the backbone of assay development, and a robust suite of services encompassing genetic counseling and research & development. Within those service offerings, genetic counseling has become an indispensable touchpoint for translating complex genomic data into actionable lifestyle guidance, while research & development services continue to propel assay optimization and novel biomarker discovery.

Shifting focus to analytical techniques, blood sampling remains the traditional mainstay for genomic assessment, complemented by minimally invasive buccal swab methods and emerging saliva-based protocols that enhance user convenience. These procedural variations enable service providers to tailor sample collection strategies to diverse clinical and consumer contexts, thereby expanding accessibility and adoption.

From a technological vantage point, bioinformatics & data analytics platforms underpin every stage of the nutrigenomic workflow, synergizing with genotyping assays, microarray technologies, next-generation sequencing, and polymerase chain reaction methodologies. Each of these technologies offers unique resolution and throughput characteristics, empowering researchers to select the optimal combination of tools for their specific investigative or diagnostic objectives.

Applications span from cancer prevention & management and comprehensive disease management-including cardiovascular health, diabetes care, and obesity interventions-to personalized nutrition programs, sports performance optimization, and targeted weight management. The disease management subdomain delves into cholesterol and hypertension control within cardiovascular health, differentiates Type 1 and Type 2 diabetes approaches, and explores endurance, pre-workout, and post-workout strategies within sports nutrition.

Finally, the end-user landscape features diagnostic laboratories, fitness & wellness centers, hospitals & clinics, and research & academic institutes. Each user segment leverages nutrigenomic insights in distinct ways, from large-scale diagnostic workflows to individualized wellness programming and academic inquiry, underscoring the breadth of applications driving sector expansion.

Understanding Regional Nuances and Market Dynamics Shaping Nutrigenomics Adoption Across the Americas, EMEA, and Asia Pacific Territories

Regional dynamics exert a profound influence on nutrigenomics adoption, with the Americas, EMEA, and Asia Pacific each exhibiting distinct growth trajectories and market conditions. In the Americas, a sophisticated healthcare infrastructure and high consumer awareness drive early adoption of advanced genetic testing services. The United States, in particular, boasts a mature ecosystem of clinical laboratories, direct-to-consumer platforms, and digital health integrators that collectively accelerate the translation of genomic insights into personalized nutrition programs.

Conversely, the Europe, Middle East & Africa region presents a heterogeneous regulatory environment. European Union member states have established rigorous data protection standards and reimbursement pathways, fostering a supportive climate for evidence-based nutrigenomic applications. Meanwhile, emerging markets in the Middle East and Africa are characterized by nascent regulatory frameworks and evolving public-private partnerships, creating both opportunities and challenges for market entrants aiming to deploy localized genomic services.

In Asia Pacific, government-led initiatives and investment in precision medicine infrastructure have catalyzed rapid expansion. Countries such as China, Japan, and Australia are prioritizing genomic research through strategic funding and supportive regulatory reforms. Consequently, regional patients and consumers benefit from increased access to nutrigenomic testing and personalized nutrition solutions. Additionally, the proliferation of digital health platforms across Asia Pacific enhances real-time data collection and remote service delivery, further amplifying market growth prospects in this dynamic region.

Analyzing Strategic Initiatives and Collaborative Ventures of Leading Industry Participants Advancing Nutrigenomics Innovation and Commercialization

Leading participants in the nutrigenomics arena have adopted multifaceted strategies to differentiate their portfolios and drive innovation. Major multinational diagnostics providers are strengthening their positions by integrating comprehensive bioinformatics solutions and launching next-generation sequencing-based panels tailored for nutritional and metabolic profiling. These efforts are frequently underpinned by strategic alliances with technology firms specializing in artificial intelligence and cloud-based analytics, enabling seamless data interpretation and scalable service deployment.

At the same time, specialized biotech firms are focusing on proprietary assay development, leveraging unique biochemical markers and advanced molecular techniques to deliver highly sensitive nutrient-gene interaction insights. Partnerships with academic research centers have facilitated co-development agreements that accelerate the identification of novel biomarkers and expand the evidentiary base supporting personalized nutrition interventions.

Moreover, contract research organizations and genetic counseling networks have enhanced their service offerings by embedding nutrigenomics modules within broader clinical trial and wellness program frameworks. These collaborations enable integrated service delivery models that combine genetic screening, result interpretation, and ongoing dietary support, thereby improving patient engagement and adherence.

Collectively, these strategic initiatives reflect a concerted effort by industry leaders to forge ecosystems that marry cutting-edge science with end-to-end service excellence. By aligning technological prowess with collaborative ventures, key companies are shaping a future in which nutrigenomic insights become an integral component of precision healthcare and personalized wellness.

Implementing Tactical Roadmaps and Strategic Priorities to Enhance Competitive Positioning and Foster Sustainable Growth in the Nutrigenomics Sector

To maintain a competitive edge, industry leaders should prioritize investments in advanced analytics capabilities and artificial intelligence-driven interpretation engines. By doing so, organizations can enhance the precision of gene-nutrient correlation models and deliver predictive dietary recommendations that evolve with real-time user data. Furthermore, diversifying supply chain partnerships and establishing localized manufacturing facilities will mitigate the impact of trade policy fluctuations while ensuring consistent access to critical reagents and assay components.

In addition, forming cross-sector alliances with academic institutions, healthcare providers, and digital health innovators can accelerate the development of integrated service platforms. These collaborations should emphasize co-created protocols for genetic counseling, result interpretation, and ongoing dietary coaching, thereby improving user engagement and clinical outcomes. Simultaneously, proactive engagement with regulatory bodies to shape emerging frameworks around data privacy, clinical validation, and reimbursement pathways will fortify market access strategies.

Moreover, investing in consumer education initiatives that demystify the science of nutrigenomics is essential. By delivering clear, evidence-based narratives through digital channels, workshops, and healthcare partnerships, organizations can build trust and foster sustained adoption. Finally, embedding robust ethical governance structures around data security and informed consent will be critical to sustaining long-term credibility. Through these concerted actions, industry leaders can drive sustainable growth and reinforce nutrigenomics as a cornerstone of personalized health management.

Employing Robust Research Techniques Integrating Qualitative Insights and Quantitative Validation to Ensure Comprehensive Nutrigenomics Intelligence

The research underpinning this report employed a multi-phase methodology combining qualitative insights and quantitative validation to ensure rigorous, actionable intelligence. Initially, expert interviews were conducted with leading scientists, clinical practitioners, and industry executives to capture firsthand perspectives on technological trends, regulatory developments, and market dynamics. These primary data points informed the development of thematic frameworks and hypothesis generation.

Subsequently, a comprehensive secondary research phase leveraged peer-reviewed journals, patent filings, regulatory publications, and specialized industry white papers to corroborate and enrich the initial qualitative findings. Analytical models were constructed to map value chains, assess competitive landscapes, and identify critical inflection points across the nutrigenomics lifecycle. Throughout this process, iterative validation workshops were held with subject matter experts to refine key assumptions and ensure alignment with real-world practices.

Finally, data triangulation techniques were applied to reconcile disparate information sources, address potential biases, and reinforce overall reliability. A final review cycle focused on clarity, coherence, and practical relevance, resulting in a report that delivers both strategic context and operational guidance. This methodological rigor provides stakeholders with a robust foundation for informed decision-making and investment in the rapidly evolving nutrigenomics field.

Consolidating Critical Findings from Technological Evolutions, Policy Impacts, and Segmentation Insights to Chart the Future Trajectory of Nutrigenomics

Throughout this summary, critical insights have emerged regarding the technological, regulatory, and market forces shaping nutrigenomics. Foundational advances in sequencing and data analytics are unlocking new dimensions of gene-nutrient interaction, while evolving trade policies are prompting adaptive strategies to preserve supply chain resilience. The segmentation framework highlights targeted opportunities across offerings, analytical techniques, technologies, applications, and end-user channels, underscoring the importance of precision positioning.

Regional analysis reveals that the Americas lead in adoption thanks to established infrastructure and consumer awareness, whereas EMEA presents both stringent regulatory standards and emerging market potential. Asia Pacific's rapid expansion is fueled by public-private partnerships and digital health integration. Leading companies are responding with strategic collaborations, proprietary assay development, and integrated service models that marry genetic counseling with advanced testing platforms.

Actionable recommendations for industry stakeholders emphasize investment in AI-driven analytics, supply chain diversification, cross-sector alliances, consumer education, and robust ethical governance. By implementing these priorities, organizations can drive sustained innovation and embed nutrigenomics as a core pillar of personalized health management. This holistic perspective provides a roadmap for navigating current challenges and capitalizing on future growth opportunities.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Adoption of AI-driven genotype-phenotype prediction to optimize personalized nutrient intake
  • 5.2. Expansion of direct-to-consumer nutrigenomic testing amid evolving regulatory frameworks
  • 5.3. Integration of multi-omics datasets to identify novel biomarkers for dietary interventions
  • 5.4. Partnerships between food manufacturers and biotech firms for gene-targeted supplement development
  • 5.5. Emergence of telehealth platforms offering real-time nutrigenomic counselling and meal planning
  • 5.6. Use of blockchain technologies to enhance privacy and security of consumer genetic data
  • 5.7. Advancements in CRISPR-based assays for rapid metabolic risk screening in nutritional genomics
  • 5.8. Development of functional foods designed from population-specific genetic polymorphism studies
  • 5.9. Application of microRNA profiling to predict individual dietary response and metabolic outcomes
  • 5.10. Collaborative research initiatives using large-scale AI analytics on global nutrigenomic data repositories

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Nutrigenomics Market, by Offering

  • 8.1. Introduction
  • 8.2. Reagents & Kits
  • 8.3. Services
    • 8.3.1. Genetic Counseling Services
    • 8.3.2. Research & Development Services

9. Nutrigenomics Market, by Technique

  • 9.1. Introduction
  • 9.2. Blood
  • 9.3. Buccal Swab
  • 9.4. Saliva

10. Nutrigenomics Market, by Technology

  • 10.1. Introduction
  • 10.2. Bioinformatics & Data Analytics
  • 10.3. Genotyping
  • 10.4. Microarray Technology
  • 10.5. Next Generation Sequencing (NGS)
  • 10.6. Polymerase Chain Reaction (PCR)

11. Nutrigenomics Market, by Application

  • 11.1. Introduction
  • 11.2. Cancer Prevention & Management
  • 11.3. Disease Management
    • 11.3.1. Cardiovascular
      • 11.3.1.1. Cholesterol
      • 11.3.1.2. Hypertension
    • 11.3.2. Diabetes
      • 11.3.2.1. Type 1
      • 11.3.2.2. Type 2
    • 11.3.3. Obesity
  • 11.4. Personalized Nutrition
  • 11.5. Sports Nutrition
    • 11.5.1. Endurance
    • 11.5.2. Post Workout
    • 11.5.3. Pre Workout
  • 11.6. Weight Management

12. Nutrigenomics Market, by End-User

  • 12.1. Introduction
  • 12.2. Diagnostic Laboratories
  • 12.3. Fitness & Wellness Centers
  • 12.4. Hospitals & Clinics
  • 12.5. Research & Academic Institutes

13. Americas Nutrigenomics Market

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. Argentina

14. Europe, Middle East & Africa Nutrigenomics Market

  • 14.1. Introduction
  • 14.2. United Kingdom
  • 14.3. Germany
  • 14.4. France
  • 14.5. Russia
  • 14.6. Italy
  • 14.7. Spain
  • 14.8. United Arab Emirates
  • 14.9. Saudi Arabia
  • 14.10. South Africa
  • 14.11. Denmark
  • 14.12. Netherlands
  • 14.13. Qatar
  • 14.14. Finland
  • 14.15. Sweden
  • 14.16. Nigeria
  • 14.17. Egypt
  • 14.18. Turkey
  • 14.19. Israel
  • 14.20. Norway
  • 14.21. Poland
  • 14.22. Switzerland

15. Asia-Pacific Nutrigenomics Market

  • 15.1. Introduction
  • 15.2. China
  • 15.3. India
  • 15.4. Japan
  • 15.5. Australia
  • 15.6. South Korea
  • 15.7. Indonesia
  • 15.8. Thailand
  • 15.9. Philippines
  • 15.10. Malaysia
  • 15.11. Singapore
  • 15.12. Vietnam
  • 15.13. Taiwan

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Atlas Laboratories Ltd.
    • 16.3.2. DNAlife
    • 16.3.3. EliteVita
    • 16.3.4. Genomics Research and Solutions Pvt Ltd.
    • 16.3.5. Genosalut Balear SL
    • 16.3.6. Genova Diagnostics Inc.
    • 16.3.7. GX Sciences, LLC
    • 16.3.8. HOLISTIC HEALTH INTERNATIONAL, LLC
    • 16.3.9. LifecodeGx Ltd
    • 16.3.10. Mapmygenome
    • 16.3.11. myDNA Life Australia Pty Ltd.
    • 16.3.12. NuGenomics
    • 16.3.13. Nutrigenomix Inc.
    • 16.3.14. Randox Health LTD
    • 16.3.15. The Gene Box
    • 16.3.16. Wellness Psychiatry, PLLC
    • 16.3.17. Xcode Life

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

LIST OF FIGURES

  • FIGURE 1. NUTRIGENOMICS MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL NUTRIGENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL NUTRIGENOMICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL NUTRIGENOMICS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL NUTRIGENOMICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 16. AMERICAS NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 18. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. NUTRIGENOMICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 24. NUTRIGENOMICS MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 25. NUTRIGENOMICS MARKET: RESEARCHAI
  • FIGURE 26. NUTRIGENOMICS MARKET: RESEARCHSTATISTICS
  • FIGURE 27. NUTRIGENOMICS MARKET: RESEARCHCONTACTS
  • FIGURE 28. NUTRIGENOMICS MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. NUTRIGENOMICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NUTRIGENOMICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NUTRIGENOMICS MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL NUTRIGENOMICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NUTRIGENOMICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL NUTRIGENOMICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NUTRIGENOMICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL NUTRIGENOMICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NUTRIGENOMICS MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL NUTRIGENOMICS MARKET SIZE, BY GENETIC COUNSELING SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NUTRIGENOMICS MARKET SIZE, BY GENETIC COUNSELING SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL NUTRIGENOMICS MARKET SIZE, BY RESEARCH & DEVELOPMENT SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NUTRIGENOMICS MARKET SIZE, BY RESEARCH & DEVELOPMENT SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL NUTRIGENOMICS MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NUTRIGENOMICS MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL NUTRIGENOMICS MARKET SIZE, BY BUCCAL SWAB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NUTRIGENOMICS MARKET SIZE, BY BUCCAL SWAB, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL NUTRIGENOMICS MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NUTRIGENOMICS MARKET SIZE, BY SALIVA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL NUTRIGENOMICS MARKET SIZE, BY BIOINFORMATICS & DATA ANALYTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NUTRIGENOMICS MARKET SIZE, BY BIOINFORMATICS & DATA ANALYTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL NUTRIGENOMICS MARKET SIZE, BY GENOTYPING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NUTRIGENOMICS MARKET SIZE, BY GENOTYPING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL NUTRIGENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NUTRIGENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL NUTRIGENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NUTRIGENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL NUTRIGENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NUTRIGENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL NUTRIGENOMICS MARKET SIZE, BY CANCER PREVENTION & MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NUTRIGENOMICS MARKET SIZE, BY CANCER PREVENTION & MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL NUTRIGENOMICS MARKET SIZE, BY CHOLESTEROL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NUTRIGENOMICS MARKET SIZE, BY CHOLESTEROL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL NUTRIGENOMICS MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NUTRIGENOMICS MARKET SIZE, BY HYPERTENSION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL NUTRIGENOMICS MARKET SIZE, BY DIABETES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NUTRIGENOMICS MARKET SIZE, BY DIABETES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL NUTRIGENOMICS MARKET SIZE, BY TYPE 1, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NUTRIGENOMICS MARKET SIZE, BY TYPE 1, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL NUTRIGENOMICS MARKET SIZE, BY TYPE 2, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NUTRIGENOMICS MARKET SIZE, BY TYPE 2, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL NUTRIGENOMICS MARKET SIZE, BY OBESITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NUTRIGENOMICS MARKET SIZE, BY OBESITY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL NUTRIGENOMICS MARKET SIZE, BY PERSONALIZED NUTRITION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NUTRIGENOMICS MARKET SIZE, BY PERSONALIZED NUTRITION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL NUTRIGENOMICS MARKET SIZE, BY ENDURANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NUTRIGENOMICS MARKET SIZE, BY ENDURANCE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL NUTRIGENOMICS MARKET SIZE, BY POST WORKOUT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NUTRIGENOMICS MARKET SIZE, BY POST WORKOUT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL NUTRIGENOMICS MARKET SIZE, BY PRE WORKOUT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NUTRIGENOMICS MARKET SIZE, BY PRE WORKOUT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL NUTRIGENOMICS MARKET SIZE, BY WEIGHT MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NUTRIGENOMICS MARKET SIZE, BY WEIGHT MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NUTRIGENOMICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL NUTRIGENOMICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NUTRIGENOMICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL NUTRIGENOMICS MARKET SIZE, BY FITNESS & WELLNESS CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NUTRIGENOMICS MARKET SIZE, BY FITNESS & WELLNESS CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL NUTRIGENOMICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NUTRIGENOMICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL NUTRIGENOMICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NUTRIGENOMICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. AMERICAS NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 92. AMERICAS NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 93. AMERICAS NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 94. AMERICAS NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 95. AMERICAS NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 96. AMERICAS NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 97. AMERICAS NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 98. AMERICAS NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 99. AMERICAS NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 101. AMERICAS NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 103. AMERICAS NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
  • TABLE 105. AMERICAS NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
  • TABLE 107. AMERICAS NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2025-2030 (USD MILLION)
  • TABLE 109. AMERICAS NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS NUTRIGENOMICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 111. AMERICAS NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 113. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 114. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 115. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 116. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 117. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 118. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 119. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 120. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 121. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 122. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 123. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 124. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 125. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 126. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
  • TABLE 127. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
  • TABLE 128. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
  • TABLE 129. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 130. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2025-2030 (USD MILLION)
  • TABLE 131. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 132. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 133. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 134. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 135. CANADA NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 136. CANADA NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 137. CANADA NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 138. CANADA NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 139. CANADA NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 140. CANADA NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 141. CANADA NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 142. CANADA NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 143. CANADA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 144. CANADA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 145. CANADA NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 146. CANADA NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 147. CANADA NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 148. CANADA NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
  • TABLE 149. CANADA NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
  • TABLE 150. CANADA NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
  • TABLE 151. CANADA NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 152. CANADA NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2025-2030 (USD MILLION)
  • TABLE 153. CANADA NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 154. CANADA NUTRIGENOMICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 155. MEXICO NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 156. MEXICO NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 157. MEXICO NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 158. MEXICO NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 159. MEXICO NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 160. MEXICO NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 161. MEXICO NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 162. MEXICO NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 163. MEXICO NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. MEXICO NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 165. MEXICO NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 166. MEXICO NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 167. MEXICO NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 168. MEXICO NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
  • TABLE 169. MEXICO NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
  • TABLE 170. MEXICO NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
  • TABLE 171. MEXICO NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 172. MEXICO NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2025-2030 (USD MILLION)
  • TABLE 173. MEXICO NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 174. MEXICO NUTRIGENOMICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 175. BRAZIL NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 176. BRAZIL NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 177. BRAZIL NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 178. BRAZIL NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 179. BRAZIL NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 180. BRAZIL NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 181. BRAZIL NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 182. BRAZIL NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 183. BRAZIL NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 184. BRAZIL NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 185. BRAZIL NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 186. BRAZIL NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 187. BRAZIL NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 188. BRAZIL NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
  • TABLE 189. BRAZIL NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
  • TABLE 190. BRAZIL NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
  • TABLE 191. BRAZIL NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 192. BRAZIL NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2025-2030 (USD MILLION)
  • TABLE 193. BRAZIL NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 194. BRAZIL NUTRIGENOMICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 195. ARGENTINA NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 196. ARGENTINA NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 197. ARGENTINA NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 198. ARGENTINA NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 199. ARGENTINA NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 200. ARGENTINA NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 201. ARGENTINA NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 202. ARGENTINA NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 203. ARGENTINA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 204. ARGENTINA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 205. ARGENTINA NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 206. ARGENTINA NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 207. ARGENTINA NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 208. ARGENTINA NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
  • TABLE 209. ARGENTINA NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
  • TABLE 210. ARGENTINA NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
  • TABLE 211. ARGENTINA NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 212. ARGENTINA NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2025-2030 (USD MILLION)
  • TABLE 213. ARGENTINA NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 214. ARGENTINA NUTRIGENOMICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2025-2030 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 238. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 240. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 242. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 243. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 244. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 245. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 247. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 248. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 249. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 250. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
  • TABLE 251. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
  • TABLE 252. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
  • TABLE 253. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 254. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2025-2030 (USD MILLION)
  • TABLE 255. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 256. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 257. GERMANY NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 258. GERMANY NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 259. GERMANY NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 260. GERMANY NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 261. GERMANY NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 262. GERMANY NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 263. GERMANY NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 264. GERMANY NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 265. GERMANY NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. GERMANY NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 267. GERMANY NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 268. GERMANY NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 269. GERMANY NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 270. GERMANY NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
  • TABLE 271. GERMANY NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
  • TABLE 272. GERMANY NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
  • TABLE 273. GERMANY NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 274. GERMANY NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2025-2030 (USD MILLION)
  • TABLE 275. GERMANY NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 276. GERMANY NUTRIGENOMICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 277. FRANCE NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 278. FRANCE NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 279. FRANCE NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 280. FRANCE NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 281. FRANCE NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 282. FRANCE NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 283. FRANCE NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 284. FRANCE NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 285. FRANCE NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. FRANCE NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 287. FRANCE NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 288. FRANCE NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 289. FRANCE NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 290. FRANCE NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
  • TABLE 291. FRANCE NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
  • TABLE 292. FRANCE NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
  • TABLE 293. FRANCE NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 294. FRANCE NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2025-2030 (USD MILLION)
  • TABLE 295. FRANCE NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 296. FRANCE NUTRIGENOMICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 297. RUSSIA NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 298. RUSSIA NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 299. RUSSIA NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 300. RUSSIA NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 301. RUSSIA NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 302. RUSSIA NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 303. RUSSIA NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 304. RUSSIA NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 305. RUSSIA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. RUSSIA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 307. RUSSIA NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 308. RUSSIA NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 309. RUSSIA NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 310. RUSSIA NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
  • TABLE 311. RUSSIA NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
  • TABLE 312. RUSSIA NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
  • TABLE 313. RUSSIA NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 314. RUSSIA NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2025-2030 (USD MILLION)
  • TABLE 315. RUSSIA NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 316. RUSSIA NUTRIGENOMICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 317. ITALY NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 318. ITALY NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 319. ITALY NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 320. ITALY NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 321. ITALY NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 322. ITALY NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 323. ITALY NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 324. ITALY NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 325. ITALY NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 326. ITALY NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 327. ITALY NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 328. ITALY NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 329. ITALY NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 330. ITALY NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
  • TABLE 331. ITALY NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
  • TABLE 332. ITALY NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
  • TABLE 333. ITALY NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 334. ITALY NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2025-2030 (USD MILLION)
  • TABLE 335. ITALY NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 336. ITALY NUTRIGENOMICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 337. SPAIN NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 338. SPAIN NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 339. SPAIN NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 340. SPAIN NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 341. SPAIN NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 342. SPAIN NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 343. SPAIN NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 344. SPAIN NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 345. SPAIN NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 346. SPAIN NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 347. SPAIN NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 348. SPAIN NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 349. SPAIN NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 350. SPAIN NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
  • TABLE 351. SPAIN NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
  • TABLE 352. SPAIN NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
  • TABLE 353. SPAIN NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 354. SPAIN NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2025-2030 (USD MILLION)
  • TABLE 355. SPAIN NUTRIGENOMICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 356. SPAIN NUTRIGENOMICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 357. UNITED ARAB EMIRATES NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 358. UNITED ARAB EMIRATES NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 359. UNITED ARAB EMIRATES NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 360. UNITED ARAB EMIRATES NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 361. UNITED ARAB EMIRATES NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 362. UNITED ARAB EMIRATES NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 363. UNITED ARAB EMIRATES NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 364. UNITED ARAB EMIRATES NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 365. UNITED ARAB EMIRATES NUTRIGENOM